Emily McDonald

Want to be an editorial fellow with us at CMI Comms? See below!

Communicable E32: Fluoroquinolones - to heal or harm? Fluoroquinolones (FQs) are valuable given their broad-spectrum activity...

🎙️ Just published a new #Communicable episode: Communicable E32: Fluoroquinolones - to heal ...

Hosted by Emily McDonald @dremilymcd.bsky.social‬
Thomas Tängdén

with invited guests:
Staffan Tevell (Karlstad, Sweden)
Bernadette Young (Oxford, UK)

Listen here:

#IDSky #Clinmicro #MedSky

📣 Next #Communicable drops Mon 28 July!
@dremilymcd.bsky.social & Thomas host Staffan Tevell (SWE) & Bernadette Young (UK) to debate #fluoroquinolones for periprosthetic joint infections #PJIs: to heal or harm? 🎙️

A follow-up on their review: www.cmi-comms.org/article/S295...

#IDSky #clinmicro

Development of machine learning prediction models for systemic inflammatory response following controlled exposure to a live attenuated influenza vaccine in healthy adults using multimodal wearable bi... Systemic inflammatory biomarkers coupled with physiological data from wearable biosensors provided rich and objective data from which to train machine learning algorithms to predict systemic inflammat...

Development of machine learning prediction models for systemic inflammatory response in adults using wearable biosensors in: a prospective controlled trial -

The Lancet Digital Health

www.thelancet.com/journals/lan...

Addressing Potentially Inappropriate Prescribing for Older Primary Care Patients This systematic review and meta-analysis evaluates the association between interventions to reduce potentially inappropriate prescribing for older primary care patients and changes in the number of me...

Findings from a new SR&MA (N=118 studies):
Interventions to reduce potentially inappropriate prescriptions significantly reduce the number of medications without increasing risk of harm. Hospitalizations and mortality were slightly reduced, though not significantly.

jamanetwork.com/journals/jam...

Communicable E30: WHO's first-ever guideline on meningitis Meningitis remains a major global health threat, with an estimated 2.5...

🎙️ Just published a new #Communicable episode: Communicab...

Hosted by Emily McDonald @dremilymcd.bsky.social
Marc Bonten @marcbonten.bsky.social

with invited guests:
Lorenzo Pezzoli & Nicolò Binello (WHO)
Jacob Bodilsen (Aalborg University)

Listen here:

#IDSky #Clinmicro #MedSky

A CADeN-led pilot study has secured funding through the @rimuhc.bsky.social’s 2025 Sustaining Excellence Grants Program!‬‬‬‬

@dremilymcd.bsky.social & team look forward to rolling out the study to compare ed. brochures vs postcards as low-cost, direct-to-patient strategies to reduce sedative use!

📣Next #Communicable drops Mon 30 Jun! @dremilymcd.bsky.social & @marcbonten.bsky.social host Lorenzo Pezzoli & Nicolò Binello (WHO) and Jacob Bodilsen (Aalborg Uni) to review key recommendations of WHO's new guideline on #meningitis & how it suits various clinical settings

#IDSky #clinmicro #MedSky

Approach to Clostridioides difficile diarrheal infection Clostridioides difficile infection (CDI) is a major cause of healthcare-associated diarrhea, with significant morbidity and mortality. CDI predominantly affects adults, with community-acquired cases o...

📣 Concise 'approach-to' review of #Cdiff infection by @lcordes.bsky.social @connorprosty.bsky.social @drtoddlee.bsky.social @dremilymcd.bsky.social w/ diagnostic algorithm & recommendations for first episodes vs relapses

www.cmi-comms.com/article/S295...

#IDSky #clinmicro #MedSky #AMR #HAI

A typical clonazepam sleeping pill travels 16300 km to arrive in Canada for use. ✈️ 🌏

And it doesn’t even work that well. 😬😫

#deprescribing for planetary health. It’s a thing.

Deprescribing Electronic Decision Support for Adults Living in Long-Term Care This stepped-wedge cluster randomized trial of long-term care home residents assesses the efficacy of an evidence-based electronic decision support tool for deprescribing potentially inappropriate med...

Findings from a new study by @dremilymcd.bsky.social et al.:

New Brunswick LTC residents were more likely to be deprescribed a potentially inappropriate med. when quarterly med. reviews were paired with MedSafer tool (adjusted odds ratio : 1.58).

Full study here: jamanetwork.com/journals/jam...

💡 Impactful Trial from @dremilymcd.bsky.social‬'s team!

The randomized trial found combining electronic deprescribing reports with regular medication reviews in long-term care homes led to a 23.7% increase in #deprescribing! 📊

Read the full article here:
buff.ly/5s5D5id

@deprescribing.bsky.social
@deprescribeus.bsky.social
@caden-recad.bsky.social

Communicable E28: Late-breaker trials at ESCMID Global: Should they change your practice? - part 2 Editors of CMI Comms, Josh Davis, Erin McCreary and Emily McDonald...

🎙️ Just published a new #Communicable episode: Communicable E28: Late-breaker trials at ESCMID Global: Should they change ...

Hosted by Josh Davis @gurujosh.bsky.social
Erin McCreary @erinmccreary.bsky.social
Emily McDonald @dremilymcd.bsky.social

Listen here:

#IDSky #Clinmicro #MedSky

Thank you!
Strong team co-led by pharmacist Carole Goodine. @newbrunswick.bsky.social

Yes, we can #deprescribe in long term care

t.co/WUixHyYmYo

Cluster randomized RCT we ran with MedSafer in New Brunswick

And by here I obviously mean hear. Although…the link is here. Below.

Penicillin allergy delabelling? Yes please! 💊 💉

Here all about the benefits on our next #communicable podcast

Erin and I have never been so happy to talk late breaker trials from @escmid.bsky.social !!

☺️☺️

#IDSky I was honored that I can present #UTI #Wikiguidelines on congress about urinary tract infections and urosepsis. Thank you @bradspellberg.bsky.social @drtoddlee.bsky.social @dremilymcd.bsky.social and others about creating such amazing movement.

Communicable E27: Late-breaker trials at ESCMID Global: Should they change your practice? - part 1 | Communicable | Episode 27 This episode of Communicable takes on a special format where editors of CMI Comms, Marc Bonten, Josh Davis, Erin McCreary, Emily McDonald, all clinical trialists in their own right, take turns to summ...

We aim to please!😊
We love that the #SNAP trial was our 1st collaboration with #Breakpoints
And that it continues: @gurujosh.bsky.social & @erinmccreary.bsky.social co-host next episode w/ @dremilymcd.bsky.social & @marcbonten.bsky.social on other latebreakers
#IDSky
share.transistor.fm/s/4d33aa77

In Canada, 1 in 4 long-term care (LTC) residents are RXed antipsychotics potentially inappropriately.

Our director @dremilymcd.bsky.social will be co-hosting the session – join to hear from experts about the new target, key findings, and steps toward safer prescribing:
ltcmeds.ca/launch-event...

Communicable E27: Late-breaker trials at ESCMID Global: Should they change your practice? - part 1 This episode of Communicable takes on a special format where editors of...

🎙️ Just published a new #Communicable episode: Communicable E27: Late-breaker trials...

Hosted by Marc Bonten @marcbonten.bsky.social
Josh Davis @gurujosh.bsky.social
Erin McCreary @erinmccreary.bsky.social
Emily McDonald @dremilymcd.bsky.social

Listen here:

#IDSky #Clinmicro #MedSky

@absteward.bsky.social

Get ready for ESCMID late breakers part 1!

Meropenem

The next #Communicable episode drops Monday, 19 May! CMI Comms editors @marcbonten.bsky.social @gurujosh.bsky.social @erinmccreary.bsky.social & @dremilymcd.bsky.social discuss key latebreaker trials presented at #ESCMIDGlobal & whether they should change your practice 🔍

#IDSky #MedSky #clinmicro

7 days if source control is the key here I think. No oral switch possible.

So glad you like😊
Backstory- @gurujosh.bsky.social suggested a series celebrating past giants/landmark papers
Then we learned CMI was by chance doing something similar:'Standing on the Shoulders of Giants'
So w/ Leonard's OK, we decided to turn it on its head
#IDSky
www.cmi-comms.com/article/S295...